Orakl Oncology

Orakl Oncology ambitions to bring back patients tumor at the center of oncology drug development for better, faster and cost-effective medicine. Our techbio platform bridges best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients. By leveraging a proprietary collection of tumor avatars, we partner with biotechs and biopharmas to match their assets with responding patients in order to value their pipeline and derisk clinical trials to boost market access.